{"version":"1.0","provider_name":"MedCity INVEST PharmaTech","provider_url":"https:\/\/events.medcitynews.com\/invest-pharmatech","author_name":"eclements","author_url":"https:\/\/events.medcitynews.com\/invest-pharmatech\/author\/eclements\/","title":"Daniel J. Hilferty - MedCity INVEST PharmaTech","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"gCDePfbWw4\"><a href=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/dan-hilferty-2\/\">Daniel J. Hilferty<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/dan-hilferty-2\/embed\/#?secret=gCDePfbWw4\" width=\"600\" height=\"338\" title=\"&#8220;Daniel J. Hilferty&#8221; &#8212; MedCity INVEST PharmaTech\" data-secret=\"gCDePfbWw4\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/events.medcitynews.com\/invest-pharmatech\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/events.medcitynews.com\/uploads\/sites\/3\/2016\/03\/Dan_Hilferty_headshot2.jpg","thumbnail_width":200,"thumbnail_height":200,"description":"Daniel J. Hilferty is president and chief executive officer of Independence Blue Cross, one of the nation\u2019s leading health insurers. \u00a0Mr. Hilferty\u2019s vision is to lead the transformation of health care in America, seeking innovative technologies and new models of care that will increase the quality and lower the cost of care. He led the&hellip;"}